Avadel Pharmaceuticals PLC (NASDAQ:AVDL) People

Avadel Pharmaceuticals PLC

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Susan Rodriguez
Other companies: Monopar Therapeutics Inc. (Chief Commercial and Strategy Officer · Since at least Mar 2, 2026); Veradigm Inc. (Director · Since at least Feb 17, 2023); Heron Therapeutics, Inc. (Director · Sep 20, 2021 – Jan 31, 2025 · Past); Ardelyx, Inc. (Chief Commercial Officer · May 18, 2020 – May 21, 2024 · Past)
Chief Operating Officer · Since at least May 13, 2025
Douglas J. Williamson
Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Jul 29, 2026); ACADIA Pharmaceuticals Inc. (Executive VP, Research & Dev · Feb 1, 2023 – Feb 10, 2023 · Past)
Chief Medical Officer · Feb 14, 2022 – Feb 14, 2022 · Past
Eric J Ende
Other companies: Matinas BioPharma Holdings, Inc. (Director · Nov 14, 2022 – Nov 1, 2023 · Past); NeuBase Therapeutics Inc (Director · Sep 9, 2022 – Sep 9, 2022 · Past)
Director · Since at least May 27, 2022
Linda Palczuk
Other companies: Verrica Pharmaceuticals Inc. (Chief Operating Officer · Jun 14, 2018 – Feb 28, 2019 · Past); Osiris Therapeutics Inc (President & CEO · Jul 10, 2017 – Jul 10, 2017 · Past)
Director · Since at least Jul 18, 2018
Naseem Amin
Other companies: Bellerophon Therapeutics Inc (Director · Jun 29, 2015 – Jun 7, 2023 · Past)
Director · Since at least May 17, 2024
Richard J Kim
Other companies: Intercept Pharmaceuticals Inc (President US Comm & Strat Mktg · May 1, 2017 – Dec 31, 2020 · Past)
Chief Commercial Officer · Feb 15, 2021 – Feb 20, 2024 · Past
Benoit Van AsscheDirector · Jun 28, 2017 – Jul 9, 2018 · Past
Dhiren D'SilvaVP Irish & European Operations · Jan 1, 2016 – Feb 7, 2018 · Past
Gregory J DivisChief Executive Officer, Director · Since at least Feb 12, 2026
Marcus W ElrodVP, Sales · Aug 29, 2016 – Jan 3, 2017 · Past
Mark Anthony McCamishDirector · Since at least Jul 29, 2025
Peter J ThorntonDirector · Since at least Jun 28, 2017
Phillandas T ThompsonSee Remarks · Dec 12, 2017 – Mar 7, 2019 · Past
Thomas S McHughChief Financial Officer · Since at least Dec 2, 2019